Ming-Fei Zhu

Ming-Fei Zhu

Auto-generated profile, based on publicly available information

Ming-Fei Zhu

Department of Gastroenterology, Peking University Third Hospital, No. 49 Huayuan North Road Haidian District, Beijing, China, puh3.net.cn

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2026 in Case Reports in Gastrointestinal Medicine
Verified
Journal Article
Open access
ZNZhan-Yue Niu
Zhan-Yue Niu
MZMing-Fei Zhu
Ming-Fei Zhu
MTMing Tao
Ming Tao
CZCheng Zhang
Cheng Zhang
FGFang Gu
Fang Gu
JLJun Li
Jun Li
Background: Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders often associated with cytogenetic abnormalities, among which trisomy 8 is one of the most common abnormalities. Trisomy 8 is linked to autoimmune manifestations, including Behçet‐like disease, especially with gastrointestinal involvement. Case Presentation: We report a rare and severe case of a 59‐year‐old male with MDS characterized by a complex abnormal karyotype, including trisomy 8, accompanied by multiple ileal perforations and intestinal ulcers resembling Behçet’s disease. Despite surgical intervention and broad‐spectrum antimicrobials, recurrent symptoms persisted. A combination of corticosteroids and thalidomide ultimately led to clinical and hematologic improvement. Methods: Clinical, radiologic, histopathologic, and cytogenetic data were collected. Literature review was conducted to contextualize diagnostic criteria and treatment strategies. Results: The patient showed hematologic and symptomatic improvement following immunosuppressive therapy. Chromosome karyotype analysis revealed chromosomal numerical abnormalities, including trisomy of chromosomes 8, 9, and 15 and the presence of an extra Y chromosome. Gastrointestinal involvement with recurrent perforations was attributed to Behçet‐like intestinal disease. Conclusion: This case underscores the aggressive clinical course and diagnostic challenges of Behçet‐like disease associated with MDS and trisomy 8, highlighting the importance of early recognition and immune‐targeted therapy.